Considering medication exposure in genomic association studies of cognition in psychotic disorders

Seenae Eum1, Scot Kristian Hill2, Jeffrey R Bishop3,4

  • 1Department of Pharmacogenomics, School of Pharmacy, Shenandoah University, Fairfax, VA 22031, USA.

Pharmacogenomics
|September 14, 2022
PubMed

Insights

Medications significantly impact cognition in psychosis-spectrum illnesses, potentially more than genetics. Accounting for medication exposure is crucial for accurate gene-cognition association studies in these disorders.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Cognitive dysfunction is a primary characteristic of psychosis-spectrum illnesses.
  • Understanding the genetic underpinnings of cognitive symptoms is vital for disease pathophysiology insights.
  • Previous genetic studies have faced challenges in identifying clear associations with cognitive deficits.

Purpose of the Study:

  • To review the contributions of pharmacological and genetic factors to cognitive function in psychosis.
  • To highlight the confounding effects of medications on gene-cognition association studies.
  • To emphasize the importance of considering medication exposure in genetic research for cognitive disorders.

Main Methods:

  • Literature review focusing on gene-cognition associations in psychosis-spectrum disorders.
  • Analysis of the impact of illness-related moderators and environmental factors, particularly medications.
  • Evaluation of the relative influence of pharmacological regimens versus individual genes on cognition.

Main Results:

  • Medication regimens, especially polypharmacy, can significantly confound gene-cognition associations.
  • The impact of medications on cognition in psychotic disorders may outweigh that of individual genes.
  • Current genetic association studies may be hindered by unaddressed medication effects.

Conclusions:

  • Medication effects are a critical confounder in genetic studies of cognition in psychosis.
  • Future research must rigorously account for medication exposure to accurately identify genetic contributions to cognitive dysfunction.
  • Pharmacological interventions may play a more substantial role in cognitive outcomes than previously recognized in genetic studies.

Related Concept Videos

Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
431
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
692
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
894
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
200